Abstracts

283 – Post-Hoc Comparison of AS01B, MF59, and Alum Adjuvants Across 4 HIV Vaccine Trials

Background Vaccine adjuvants enhance humoral and cellular responses but may induce reactogenicity. AS01B, MF59, and Alum have distinct mechanisms, yet head-to-head comparisons of immunogenicity and reactogenicity are scarce. Methods We conducted a cross-protocol, post-hoc, analysis of four randomized, controlled, double-blind trials (HVTN 100, 107, 120, and 702) of adults without HIV who received ALVAC-HIV (vCP2438)…

1025 – Incident Chlamydia and Gonorrhea Infections Among People Vulnerable to HIV in Kenya, 2021-2024

Background Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections can cause adverse health outcomes and facilitate HIV transmission. CT/NG rates in sub-Saharan Africa are increasing, with Kenya among the countries with the highest burden of HIV. However, recently estimated Kenyan CT/NG rates are limited or biased. Methods Between 12/2021 and 4/2023, we enrolled participants in Kericho…

1065 – Feasibility, Uptake, and Early Outcomes of the Cutting Out Stigma Barbershop HIV Intervention

Background Black Americans and individuals in the Southern United States bear a disproportionate burden of HIV. To address stigma, a key contributor to these disparities, we developed Cutting Out Stigma (COS), a barbershop-based education and multimedia intervention in Tennessee (TN). Methods We recruited and trained TN barbers as COS Men’s Health Ambassadors.Trained barbers were eligible to participate in…

622 – Mortality for Cancer in PWH Compared to the General Population: Data From ICONA Cohort, 2006-2023

Background Malignancies represent a persistent burden of morbidity and mortality in people with HIV (PWH). The study aimed to compare cancer-related mortality in PWH with the Italian general population. Methods All antiretroviral naïve PWH enrolled in the ICONA cohort (2006-2023) were included. Demographic and clinical characteristics were collected from ICONA database. Deaths caused by cancer (virus-related and…

1085 – PEPFAR-Supported Sites in Sub-Saharan Africa Exposed to Conflict in 2024

Background Sub-Saharan African countries supported by the President’s Emergency Plan for AIDS Relief (PEPFAR) frequently experience conflict events such as battles, explosions, riots, and violence against civilians. These events can disrupt the continuity of antiretroviral therapy (ART) treatment for people living with HIV. Understanding the scope of conflict exposure on PEPFAR-supported sites and their beneficiaries is…

1100 – Advancing the 3rd “95”: Evidence From DSD and Multimonth Dispensing Models in Kampala, Uganda

Background Differentiated service delivery models (DSDM) for antiretroviral therapy (ART), including multi-month dispensing (MMD), have been scaled up to improve treatment outcomes and reduce the burden on HIV care programs. However, evidence on their contribution to sustained virological suppression (3rd 95) within Ugandan programmatic settings remains limited. We examined the contribution of DSDM and MMD…

373 – Long-Term Passive Infusion of Broadly Neutralizing Antibodies With Markedly Enhanced ADCC

Background Broadly neutralizing antibodies (bNAbs) can suppress diverse HIV strains and are being explored for long-term protection. Although our lab has demonstrated that long-term expression of AAV-delivered bNAbs can lead to a functional cure, persistent viral reservoirs are still detectable for many years. To better target this reservoir, we evaluated the deliverability and antiviral potential of…

1107 – Short-Term Poverty Relief and ART Adherence: Insights From a Natural Experiment of SNAP Recipients

Background ART adherence is essential for favorable HIV outcomes, yet suboptimal adherence persists, particularly among low-income populations. Scarcity theory posits that economic hardship imposes cognitive burdens that undermine health behaviors like adherence, implying that alleviating scarcity may improve adherence. The Supplemental Nutrition Assistance Program (SNAP), the largest US anti-poverty program, has two features that create…